Day 1-Tuesday, 8 th February Chair Person : Dr. Judy Sullivan Moderator : Kamal Boukef. Time Topic Speaker
|
|
|
- Isabella Rogers
- 8 years ago
- Views:
Transcription
1 07:30 am - 08:30 am Registration Organization & Quality Session Day 1-Tuesday, 8 th February Chair Person : Dr. Judy Sullivan Moderator : Kamal Boukef 08:30 am - 08:45 am Lean Practice in Blood Banking Laboratories. Mr. Sebastien Van den Berghe 08:45 am - 09:00 am Six Sigma Deployment in Kuwait Public Healthcare: A Case Study of Kuwait Central Blood Bank Dr. Mohamed Al-Mazedi 09:00 am - 09:15 am Implementation of Internal Assessment. Dr. Michel Breard 09:15 am - 09:30 am 09:30 am - 09:45 am Implementation of Training and Competency. Is it Validation or Quality Control. Dr. Jane Norris Dr. Michel Breard 09:45 am - 10:00 am 10:00 am - 10:30 am Disaster Management Session Chair Person : Dr. Michel Breard Moderator: Kareem Yarfas 10:30 am - 10:50 am 10:50 am - 11:10 am 11:10 am - 11:30 am 11:30 am - 11:50 am 11:50 am - 12:00 pm Management of Bleeding in Blood Shortage Periods. Coordinating the Nation s Blood Supply During Disasters. Managing Blood Shortages Times in Kuwait. Management of Stock in Disasters/Supply Limitation. Dr. Suzanne Bakdash Dr. Arwa Awn Dr. Rana Al-Abdulrazzak Dr. Suzanne Bakdash 12:00 pm - 02:00 pm Lunch and Lunch Symposium. 37
2 Donor and Donation Session (1) - New Blood for the world Chair Person: Dr. Suzanne Bakdash Moderator: Dr. Rana Al-Abdulrazzak 02:00 pm - 02:20 pm The Role of Donor Associations in Promoting Blood Donation Cultures. Dr. Neils Mikelsen 02:20 pm - 02:40 pm 02:40 pm - 02:50 pm 02:50 pm - 03:00 pm 03:00 pm - 03:10 pm 03:10 pm - 03:30 pm 03:30 pm - 04:00 pm Club 25 Initiative From Zimbabwe to the World. Kuwait 25 Club. Egypt 25 Club. Assessment of Motivating & Demotivating Factors for Voluntary Blood Donation Among Khartoum Universities Students Dr. Diane De Coning Dr. Rana Al-Abdulrazzak Dr. Faten Moftah Dr. Mohammed Zahran Donor and Donation Session (2) - New Blood for the world Chair Person : Dr. Diane De Coning Moderator: Dr.Hind Al-Humaidan 04:00 pm - 04:20 pm 04:20 pm - 04:35 pm 04:35 pm - 04:50 pm 04:50 pm - 05:05 pm 05:05 pm - 05:20 pm 05:20 pm - 05:30 pm Legal and ethical aspects of Voluntary Blood Donation. Automated Blood Component Collection. Automated Blood Component Collection in Kuwait. The Plasma Fractionation Project in the Kingdom of Saudi Arabia. New Methods for Fractionation a Presentation of the Small Pool Fractionation System Developed in Egypt. Dr. Neils Mikelsen Dr. Giancarlo Ferrazza Dr. Ranjita Sharma Dr. Ibraheem Al-Omar Dr. Majdy Elekiaby 38 22
3 07:30 am - 08:30 am Registration Clinical Transfusion Session 1 Day 2-Wednesday, 9 th February Chair Person : Dr. Neils Mikelsen Moderator: Dr.Raja a Maroof 08:30 am - 08:50 am The Significant of Accreditation in Hospital Blood Banks. Dr. Judith Ann Sullivan 08:50 am - 09:10 am Modern Ethical Issues in Patient Blood Management. Dr. Kathleen Sazama 09:10 am - 09:25 am Auditing of Blood Utilization. Dr. Faten Moftah 09:25 am - 09:45 am Improvement in Blood Utilization in a General Hospital: The New Role of the Patient Blood Management (Formerly the Transfusion Review) Committee. Dr. Kathleen Sazama 09:45 am - 10:00 am 10:00 am - 10:30 am Clinical Transfusion Session 2 Chair Person : Dr. Jean Pierre Cazenove Moderator: Samia Abdulsalam 10:30 am - 10:50 am 10:50 am - 11:10 am 11:10 am - 11:30 am 11:30 am - 11:45 am 11:45 am - 12:00 pm Complications and Prognosis of Preoperative Blood Transfusion. Monitoring and Assessing Transfusion Process. Blood Transfusion Management in Liver Transplant. Use of Epo as Alternative to Transfusion. Dr. Omer Al Radwan Mrs. Maggie Comac Dr. Omer Al Radwan Dr. Shaikha Almuhareb 12:00 pm - 02:00 pm Lunch and Lunch Symposium. 39
4 Clinical Transfusion Session 3 Chair Person : Dr. Paulo Rebulla Moderator: Hanan Al- Wazan 02:00 pm - 02:15 pm 02:15 pm - 02:30 pm 02:30 pm - 02:45 pm 02:45 pm - 03:00 pm 03:00 pm - 03:15 pm 03:15 pm - 03:30 pm 03:30 pm - 04:00 pm Management of Chronically Transfused Patients. Therapeutic Aphaeresis Complications. Platelet Transfusion: Optimal Timing and Dose in Thrombocytopenic Patients. Safe and Rational Use of Blood Products Towards the End of Life. Clinical Use of Plasma. Dr. Giancarlo Ferrazza Dr. Hind Al-Humaidan Dr. Paulo Rebulla Dr. Renee McCulloch Dr. Magdy Elekiaby Hemovigilance & Traceability of Blood Transfusion Chair Person: Dr. Jane Norris Moderator: Dr.Arwa Awn 04:00 pm - 04:15 pm 04:15 pm - 04:30 pm 04:30 pm - 04:45 pm 04:45 pm - 05:00 pm 05:00 pm - 05:15 pm 05:15 pm - 05:30 pm Aabb Hemovigilance Working Group. Hemovigilance System in UK. Hemovigilance System in France. Hemovigilance System in Arabian Countries. An International Active Hemovigilance Program to Characterize The Safety and Efficacy of Platelet and Plasma Components Prepared with Pathogen Inactivation: A Six Year Experience. Dr. Michel Breard Dr. J P Allain Dr. Jean Pierre Cazenave Dr. Kamel Boukef Dr. Larry corash 40 07:00 pm Gala Dinner with big social event Al Hashemi Grand Ballroom, Radisson Blu Hotel, Kuwait.
5 Day 3-Thursday, 10 th February :30 am - 08:30 am Registration Blood Safety Session 1 Chair Person: Dr. James P. AuBuchon Moderator: Dr.Faten Moftah 08:30 am - 08:50 am Advances in Sereologicalnat Assays for Screening of Blood Donors for Infectious Agents. Dr. Mike Busch 08:50 am - 09:05 am Hepatitis Associated with Blood Transfusion. Dr. J P Allain 09:05 am - 09:20 am Infectious Control Practices of Blood Transfusion Services in Yemen, KAP analysis. Dr. Arwa Own 09:20 am - 09:40 am 09:40 am - 10:00 am Kuwait Experience of Screening of Blood Donors. Dr. Reem Al-Radwan 10:00 am - 10:30 am Blood Safety Session 2 Chair Person: Dr. J P Allain Moderator: Dr. Reem Al-Radwan 10:30 am - 10:50 am 10:50 am - 11:10 am 11:10 am - 11:25 am 11:25 am - 11:45 am 11:45 am - 12:00 pm Implementation of Appropriate Screening Protocol for Donor Screening. Pathogen Inactivation: Current Status and Implementation Cosniderations. A Five Year Practical and Clinical Experience with the Implementation In A French Regional Transfusion Center of Pathogen Inactivation of Platelets and Plasma. Decision Analysis in Transfusion Medicine. Dr. Mike Busch Dr. James P. AuBuchon Dr. Jean Pierre Cazenove Dr. James P. AuBuchon 12:00 pm - 02:00 pm Lunch and Lunch Symposium. 41
6 Cellular Therapy Session Chair Person: Dr. Mike Busch Moderator: Dr. Ibraheem Al-Omar 02:00 pm - 02:20 pm 02:20 pm - 02:35 pm 02:35 pm - 02:50 pm 02:50 pm - 03:05 pm 03:05 pm - 03:20 pm 03:20 pm - 03:30 pm 04:00 pm Report on 18 Years of Cord Blood Banking and Transplant from the Milano Cord Blood Bank. National Cord Blood Banking in Saudi Arabia. Optimal Cord Blood Banks in Europe to Improve Transplantation Outcomes. Bone Marrow and Stem Cell Transplantation in Kuwait. Non Hematological Applications of Cord Blood Banking. Closing Sessions. Dr. Paulo Rebulla Dr. Hind Al-Humaidan Dr. Sergi Querol Dr. Salem Al Shemmary Dr. Paulo Rebulla Closing Session Chair Person: Karim Yarfas Moderator: Dr. Reem Al Radwan 04:00 pm - 04:20 pm 04:20 pm - 05:00 pm 05:00 pm Over view of Conference Reading Recommendation Closing Dr. Reem Al Radwan Dr. Kareem Yarfas 42 22
Sponsors: Agenda. 2013 BioArchive Users Meeting. Liège, Belgium 23-24 May 2013
2013 BioArchive Users Meeting Liège, Belgium 23-24 May 2013 Agenda Wednesday 22 May 1730 Arrival Ramada Plaza Hotel Liège Quai Saint-Léonard 36 4000 Liège Belgium 0032 (0)4 228 81 73 Thursday 23 May 0800
NORTHWEST TRANSFUSION SYMPOSIUM. Final Program. Tacoma, Washington 9/12/2015
2015 NORTHWEST TRANSFUSION SYMPOSIUM Final Program Tacoma, Washington 9/12/2015 Table of Contents Learning Objectives...2 Accreditation...3 Disclosure Policy...3 Committee Members...4 Speaker Schedule...5
Red blood cell transfusions in the Netherlands Towards (very) low use
Red blood cell transfusions in the Netherlands Towards (very) low use Marian G.J. van Kraaij, MD PhD hematologist/ transfusion medicine specialist Director Dept Transfusion Medicine Sanquin Blood Supply,
International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007
International NetCord Foundation Executive Committee Conference Call Minutes Committee Members: Board Members: Staff: President Joan Garcia and Drs. Yves Beguin and Elizabeth Shpall Drs. Cristina Navarrete
DEPARTMENT OF HEALTH AND HUMAN SERVICES. Health Resources and Services Administration. Advisory Council on Blood Stem Cell Transplantation
This document is scheduled to be published in the Federal Register on 01/21/2016 and available online at http://federalregister.gov/a/2016-01127, and on FDsys.gov Billing Code 4165-15 DEPARTMENT OF HEALTH
Need for Expansion of BTS. Insufficient Space
For discussion on 17 November 2014 LC Paper No. CB(2)242/14-15(07) Legislative Council Panel on Health Services Expansion of the Hong Kong Red Cross Blood Transfusion Service Headquarters Purpose This
15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com. April 17, 2015.
15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com April 17, 2015 Dear Shareholder, We are experiencing exciting times at HemaCare. Over the course of
»medical programs and services. transfusion medicine fellowship program
»medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers
6th Annual. Children s Medical Center Transfusion & Laboratory Medicine Conference February 13-15, 2013
6th Annual Transfusion & Laboratory Medicine Conference February 13-15, 2013 About Children s Medical Center is accredited by the Joint Commission on Accreditation of Healthcare Organizations and has received
Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center
(last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical
It s not something you want to think about, but it s something you want to prepare for.
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
»medical programs and services. transfusion medicine fellowship program
»medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers
Cord blood donation is a painless and free gesture, helping others and saving lives.
Cord blood donation is a painless and free gesture, helping others and saving lives. Cord blood, a bond for life. GRANDE CAUSE NATIONALE 2009 Donation for scientific research If your donation does not
ASH Review. Wednesday, January 21, 2015. Renaissance Cleveland Hotel. 24 Public Square Cleveland, Ohio. 15th Annual
15th Annual ASH Review Wednesday, January 21, 2015 24 Public Square Cleveland, Ohio About the Course This course will provide hematologists, medical oncologists, radiation oncologists and nurses with current
A Gift for life. HTA Licence No. 22653
A Gift for life HTA Licence No. 22653 2 3 the best possible gift for your new born child. 4 6 8 9 10 12 14 16 19 what is cord blood current treatments services contents properties for treatment process
Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape
GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us
The Cord Blood Industry and Be The Match
The Cord Blood Industry and Be The Match Arthur Busse Manager of Business Analytics NMDP: Be The Match Sept. 11, 2015 Be The Match Mission Saving Lives with cellular therapy through science, service and
Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
Red Blood Cell Transfusions for Sickle Cell Disease
Red Blood Cell Transfusions for Sickle Cell Disease Red Blood Cell Transfusions for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital, Departments of Hematology, Patient Education,
UMBILICAL CORD BLOOD BANKING. A guide for parents
UMBILICAL CORD BLOOD BANKING A guide for parents This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please visit https://go.edqm.eu/transplantation.
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient
CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM
APPENDIX A SAMPLE CONSENT FORM CORD BLOOD TRANSPLANTATION (COBLT) STUDY SAMPLE CONSENT FORM FOR THE EXPANDED ACCESS PROTOCOL You (your child) are being asked to take part in a clinical research study.
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC ISCT Conference, New Zealand, April 2013 April 1 st 2013 NIBSC will become part of the Medicines and
International NetCord Foundation Executive Committee Conference Call Minutes May 21, 2014
International NetCord Foundation Executive Committee Conference Call Minutes May 21, 2014 Committee Members: Staff: President Etienne Baudoux and Drs. Gesine Koegler, Joanne Kurtzberg, Alexander Platz
Sepax. your child s cord blood is in safe hands. World leader in adult stem cell processing
Sepax your child s cord blood is in safe hands World leader in adult stem cell processing Biosafe Experience Credibility Innovation Dear Customer, Innovation in cell processing is our credo and this is
Cellular Therapy Liaison Meeting 10 September 2009 BECS. M. Allene Carr-Greer, MT(ASCP)SBB Director, Regulatory Affairs AABB
Cellular Therapy Liaison Meeting 10 September 2009 BECS M. Allene Carr-Greer, MT(ASCP)SBB Director, Regulatory Affairs AABB Definition from October 2007 draft guidance BECS Validation In the User s Facility
Donation of Umbilical Cord Blood. A precious life offer. for everyone!
Donation of Umbilical Cord Blood A precious life offer for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Page 3 Hellenic Cord Blood Bank Page 4 Haematopoietic Progenitor
Information for patients needing irradiated blood
Information for patients needing irradiated blood Patient information I am at risk of transfusion-associated graft-versus-host disease If I need to have a blood transfusion, cellular blood components (Red
ASPIRATION ASPIRATIO 09 HSA ANNUAL REPORT 10
ASPIRATION ASPIRATIO ASPIRATION 09 HSA ANNUAL REPORT 10 NBLOOD SERVICES GROUP The Blood Services Group is dedicated to securing the safety and stability of Singapore s blood supply. Our stringent quality
cord blood saves lives...
cord blood saves lives... ...by providing a rich source of blood stem cells that can be used to treat over 80 different diseases including leukemia, lymphoma, thalassemia, Tay-Sachs and sickle cell anemia.
umbilical cord blood banking A guide for parents
umbilical cord blood banking A guide for parents 2 nd Edition 2016 This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please
NHS BLOOD AND TRANSPLANT 26 NOVEMBER 2009 CHIEF EXECUTIVE S REPORT
09/84 NHS BLOOD AND TRANSPLANT 26 NOVEMBER 2009 CHIEF EXECUTIVE S REPORT INTRODUCTION Since my last report, I have spent a proportion of my time on a number of outward facing events aimed at raising the
FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP
FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP WEDNESDAY 01/07/2015 Morning Parallel Sessions Cord Blood Banking Cellular Therapy/Regenerative Medicine
Australian Bone Marrow Donor Registry PROTECTING YOUR PRIVACY OUR PRIVACY POLICY
Australian Bone Marrow Donor Registry PROTECTING YOUR PRIVACY OUR PRIVACY POLICY WHO ARE WE? The Australian Bone Marrow Donor Registry (ABMDR) is a non-profit organisation that manages the processes of
Blood cells are vital to the human body
Candide FONT-SALA Blood cells are vital to the human body Red cells transport oxygen From http://www.english-online.at/biology/blood/blood-supply-and-blood-diseases.htm Red cell life span 120 days 200
LifeNet Health Presented by James Clagett, PhD., Chief Science Officer LifeNet Health - The Best Keep Secret in Regenerative Medicine
Presented by James Clagett, PhD., Chief Science Officer - The Best Keep Secret in Regenerative Medicine Corporate Headquarters Virginia Beach, VA Who is? helps save lives and restore health for thousands
Corporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
UMBILICAL CORD BLOOD BANKING A guide for parents
UMBILICAL CORD BLOOD BANKING A guide for parents 2 nd EDITION INTRODUCTION The cells contained in the umbilical cord blood have therapeutic value for the treatment of blood disorders and immune diseases.
FE, HIGH STANDARDS, STATE- F-THE-ART, PATIENT-FOCUSED, CORD BLOOD LABORATORIES
FE, HIGH STANDARDS, STATE- F-THE-ART, PATIENT-FOCUSED, FE, HIGH STANDARDS, STATE- F-THE-ART, PATIENT-FOCUSED, FE, HIGH STANDARDS, STATE- F-THE-ART, PATIENT-FOCUSED, FE, HIGH STANDARDS, STATE- F-THE-ART,
Cord Blood Market Trends, circa 2014
GENReports: Market & Tech Analysis Cord Blood Market Trends, circa 2014 > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Topic Introduction and Scope The focus of this GEN
PACT Web Seminar July 19, 2007
PACT Web Seminar July 19, 2007 Phyllis I. Warkentin, MD Professor, Pathology and Pediatrics University of NE Medical Center Medical Director Chairman, Accreditation Program Foundation for the Accreditation
Cord Blood Stem Cell Transplantation
LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral
No. 43/2007 The role of the state in establishing a public cord blood stem cell bank i
No. 43/2007 The role of the state in establishing a public cord blood stem cell bank i By Professor Vernon Louw MMed MBChB (Stell), Int.Med (Stell), Certified Clinical Haematologist (Leuven, Belgium) Associate
International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014
International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014 Committee Members: Staff: President Etienne Baudoux and Drs. Gesine Koegler, Joanne Kurtzberg and Alexander
Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations
Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Basic principles are established and the responsibilities of the national government are clarified in
NACP IV Working Group on Blood safety
NACP IV Working Group on Blood safety 1 st round of consultation I. Current status of blood safety: 1 Total blood collection increased from 4.4 million units in 2007 to 7.9 million units in 2011. 2 Incidence
Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale
Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Topics 1- NetCord-FACT: l organizzazione internazionale ed il suo scopo 2- Le norme di qualità sul bancaggio
TRANSFUSION MEDICINE
TRANSFUSION MEDICINE Transfusion medicine is a one-month per year rotation for a total of three months. During each rotation the resident is exposed to the basic concepts of transfusion medicine. Specific
Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods Blood Products Advisory Committee, March 9, 2006 Steven Kleinman, MD Senior Medical Advisor, AABB Co-chair, AABB
What we will discuss today
Umbilical cord blood banking It s Utility? Dr. Nita Radhakrishnan Pediatric Hematology Oncology Unit, Sir Ganga Ram Hospital, New Delhi What we will discuss today What are stem cells? What are the sources
THERMOGENESIS REPORTS THIRD QUARTER RESULTS; REDUCES NET LOSS BY 60 PERCENT
THERMOGENESIS REPORTS THIRD QUARTER RESULTS; REDUCES NET LOSS BY 60 PERCENT RANCHO CORDOVA, CA, (May 6, 2009) ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services
consider any person to be acting in concert with it for purposes of the Offer in accordance with the CMSA.
PRESS RELEASE Cordlife Increases Its Interest In Malaysia Listed Stem Cell Banking Company StemLife Berhad To 33.03% And Extends Conditional Mandatory Take-Over Offer For Remaining Shares - Acquisition
Search Coordinator Certificate
Educational. Expert led. E learning. Information and registration Educational. Expert led. E learning. Professionals involved in unrelated adult donor/cord blood unit search and selection are essential
SAVE A LIFE... BY GIVING LIFE!
SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the
CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE
CORD BLOOD BANKING IN BRAZIL HOSPITAL ISRAELITA ALBERT EINSTEIN S EXPERIENCE JOSÉ MAURO KUTNER, MD MEDICAL DIRECTOR BLOOD BANK Brazil - South America BARCELONA * * SÃO PAULO Brazil - South America Brazil
Directed/Related Cord Blood Collection by NHS Blood and Transplant
Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why
The Future of Cord Blood Banking in Canada
The Future of Cord Blood Banking in Canada Lorraine Sheremeta 1, Margo Plant 2 & Bartha Maria Knoppers 2 Abstract The potential clinical utility of umbilical cord blood (UCB) as a source of stem cells
Ethical and Regulatory Challenges of Stem Cell Research and Applications at Health Care System in UAE. Dr. Waleed Al Faisal & Dr.
Ethical and Regulatory Challenges of Stem Cell Research and Applications at Health Care System in UAE Contents Background Objectives Methods Findings Conclusions and recommendations Stem Cell Stem cells
Cord blood donation is a painless and free gesture, helping others and saving lives. Cord blood, a bond for life.
Cord blood donation is a painless and free gesture, helping others and saving lives. Cord blood, a bond for life. What is cord blood? Cord blood (or placental blood) is the blood that remains in the placenta
OneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04
OneMatch National Public Cord Blood Bank Blood Matters 2011 Sue Smith, Executive Director, Stem Cells 2011-11- 04 No Disclosures To Declare The presenter does not have any involvement with the industry
Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center
Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center Discuss Quality dashboards as auditing and Reporting Methods for Quality Management Provide examples
NATIONAL HEALTH SERVICE. NHS Blood and Transplant (Gwaed a Thrawsblaniadau r GIG) (England) Directions 2005
NATIONAL HEALTH SERVICE NHS Blood and Transplant (Gwaed a Thrawsblaniadau r GIG) (England) Directions 2005 This version incorporates the following Amendment Directions: NHS Blood and Transplant (England)
Role of the Medical Director
Role of the Medical Director Beth Shaz, MD Assistant Professor, Emory University School of Medicine Director, Transfusion Services, Grady Memorial Hospital Atlanta, GA 1.1.1 Medical Director Responsibilities
OUR JOURNEY THROUGH THE YEARS
The King Faisal Specialist Hospital and Research Centre Experience in Hematology, Oncology and Bone Marrow Transplantation OUR JOURNEY THROUGH THE YEARS REGGIE BELKHEDIM A Brief Overview: King Faisal Specialist
Suggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction
Suggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction March 27, 2014 Steve Kleinman, MD TRALI: A brief history Identified as a non-infectious serious hazard of transfusion in the
CORDLIFE LAUNCHES ASIA S LARGEST PRIVATE CORD BLOOD STORAGE FACILITY
NEWS RELEASE CORDLIFE LAUNCHES ASIA S LARGEST PRIVATE CORD BLOOD STORAGE FACILITY - Fully-owned facility with capacity expansion to further entrench leadership position and enable economies of scale -
Helping Cancer Patients through Blood Donation
Helping Cancer Patients through Blood Donation Guest Expert: Edward, MD Professor of Lab Medicine Paul CEO, CT Red Cross www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with
Management Discussion and Analysis dated August 24, 2010, to accompany the financial statements for the year ended May 31, 2010
L I F E B A N K TM Corp. Saving Life s Most Precious Cells Technology Place BCIT Campus Suite 200 4475 Wayburne Drive Burnaby, British Columbia V5G 4X4 Tel: 604-738-2722 Fax:604-738-2726 info@lifebank.com
Corporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy
Improving Quality in Cellular Therapy with FACT Accreditation The Foundation for the Accreditation of Cellular Therapy 1 Goals and Services of FACT Promote quality patient care and laboratory practice
FINAL SCHEDULE YEAR 1 AUGUST 18 22 WEEK 1
YEAR 1 AUGUST 18 22 WEEK 1 TIME MONDAY (18) TUESDAY (19) WEDNESDAY (20) THURSDAY (21) FRIDAY (22) 11am 1 LUNCH LUNCH LUNCH LUNCH LUNCH 3 YEAR 1 AUGUST 25 29 WEEK 2 TIME MONDAY (25) TUESDAY (26) WEDNESDAY
A Public Cord Blood Bank for South Africa? i
No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African
Future Health Technologies. From Academia to Industry The Stem Cell Challenge. Roger J. Dainty MBE FIScT UK Managing Director
Future Health Technologies From Academia to Industry The Stem Cell Challenge Roger J. Dainty MBE FIScT UK Managing Director How Did I Get Here? Working as a Research Medical Technician (Birmingham University
CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire
CAREERS IN BIOMEDICAL SCIENCE & THE IBMS Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire What is a biomedical scientist? Biomedical scientists carry out investigations
Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014
FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow
Global Database on Blood Safety
Global Database on Blood Safety Summary Report 2011 1 Key facts Global Blood Collection: Around 92 million blood donations are collected annually from all types of blood donors (voluntary unpaid, family/replacement
IMPROVING CORD BLOOD BANK OPERATIONAL EFFICIENCY
IMPROVING CORD BLOOD BANK OPERATIONAL EFFICIENCY Francesc de Haro Partner, Blood Bank Solutions, Barcelona (Spain) francescdeharo@bloodbanksolutions.es INTRODUCTION Cord Blood Banks (CBBs) activities started
4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
CORD BLOOD BANKING FAQ
CORD BLOOD BANKING FAQ Cord Blood & Stem Cells Q: What is umbilical cord blood (UCB)? A: Bone marrow, peripheral blood and UCB constitute the three primary sources of stem cells. Cord blood, which, until
CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD
The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes
HOUSE BILL REPORT HB 2805
HOUSE BILL REPORT HB 2805 Title: An act relating to umbilical cord blood. As Reported by House Committee On: Health Care & Wellness Appropriations Brief Description: Regarding the collection of umbilical
Hematopoietic stem and progenitor cell transplants: regulation and accreditation
Pediatr Transplantation 2003: 7 (Suppl. 3): 101 108 Printed in UK. All rights reserved Copyright Ó 2003 Blackwell Munksgaard Pediatric Transplantation ISSN 1398-2265 Hematopoietic stem and progenitor cell
Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence
Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence August 2015 Title: Triennial Review of NHS Blood and Transplant Call for Evidence Author:
How To Become A Doctor
Page 1 of 8 Rank Name PHS #, Medical Officer, CV cover sheet, Date PROFESSIONAL QUALIFICATIONS 8/97-7/99 Senior Staff Fellow, National Institutes of Health (NIH), Dept. of Transfusion Medicine 7/1995 Board
Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095
Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095 CS 6.4 DIAGNOSIS AND MANAGEMENT OF CYTOMEGALOVIRUS (CMV) INFECTION AND DISEASE Location:
Hippocrates, Cords and Quality
Hippocrates, Cords and Quality Transfusion Medicine Resident Education Seminar April 3,2012 Renee Naiman, Director, Quality and Regulatory Affairs Overview -Brief update of cord blood history and usage.
Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low
Upstate Cord Blood Bank Hematopoietic Progenitor Cells Hematopoiesis i starts from self renewing HPC HPC differentiates t to sequentially more mature blood cells HPC circulate in very low numbers in adults
A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS
A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can
PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank
Cordblood Stem Cells and The Role of Cordblood Bank in Supporting Stem Cells Research Presentation Overview Company profile Haematopoietic stem cells in cordblood What we can do to help 1 2 PT CordLife
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION
The Danish Bone Marrow Donor Registry DBMDR
The DBMDR Vision To achieve and maintain a position as an internationally recognized hematopoietic stem cell donor registry with respect to high quality of donor data base and HLA typing, individualized,
CONSENT FORM. Cord Blood Banking for Transplantation
Cord Blood Program Northwest Tissue Center/Puget Sound Blood Center 921 Terry Avenue Seattle, WA 98104 (206) 292-1896 Swedish Medical Center 747 Broadway Seattle, WA 98122 (206) 386-6000 CONSENT FORM Cord
STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE
STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem
A Real Time Lab for Pan Canadian Innovation Leveraging Canadian Blood Services Model for Better Value to Health care Systems
A Real Time Lab for Pan Canadian Innovation Leveraging Canadian Blood Services Model for Better Value to Health care Systems November 14, 2014 Submission to the Advisory Panel on Health Care Innovation
TERUMO Corporation Business Strategy Conference
TERUMO Corporation Business Strategy Conference THERAPEUTIC SYSTEMS & CELL PROCESSING MARK FLOWER GLOBAL MARKETING December 5, 2011 Regenerative Medicine, Cell Therapy, & Cell Processing Regenerative Medicine
THE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE
FACTS AND FIGURES JUNE 2004 NO 2 THE PREPARATION OF SINGLE DONOR CRYOPRECIPITATE Revised Edition Shân Lloyd National Blood Transfusion Service Zimbabwe Published by the World Federation of Hemophilia (WFH);
Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.
Blood Transfusion Introduction Blood transfusions can save lives. Every second, someone in the world needs a blood transfusion. Blood transfusions can replace the blood lost from a serious injury or surgery.
SMF Awareness Seminar 2014
SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD